Literature DB >> 10885739

Adverse effects of antiepileptic drugs.

R S Greenwood1.   

Abstract

Because the efficacies of antiepileptic drugs (AEDs) are often equivalent, selection of an AED is often determined by adverse effects. Differences in methods for labeling adverse effects and in the adverse effect terms themselves, variations in the populations studied, and inconsistent classifications of adverse effects make it difficult to know how to use information on adverse effects to choose an AED. Effort is underway to develop more extensive and internationally acceptable descriptive terms for adverse effects. Comparison of adverse effects in patients taking AEDs with adverse events in control groups is helpful; however, data from controlled studies are often lacking for most AEDs. Because of these limitations, the clinician must adopt a preventative and early detection approach based on some general principles. This review outlines factors to consider for avoiding and detecting AED adverse effects. The occurrence of weight change with AEDs is reviewed extensively, serving to illustrate how the principle factors can be used to avoid and manage adverse effects and where there is need for better studies of the short- and long-term adverse effects of AEDs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885739     DOI: 10.1111/j.1528-1157.2000.tb01523.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

1.  The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.

Authors:  Andrew Lloyd; Emma McIntosh; Martin Price
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience.

Authors:  Shelly Lwu; Mark G Hamilton; Peter A Forsyth; J Gregory Cairncross; Ian F Parney
Journal:  J Neurooncol       Date:  2009-08-08       Impact factor: 4.130

3.  Genetic and environmental correlates of topiramate-induced cognitive impairment.

Authors:  Elizabeth T Cirulli; Thomas J Urban; Susan E Marino; Kristen N Linney; Angela K Birnbaum; Chantal Depondt; Deborah K Attix; Rodney A Radtke; David B Goldstein
Journal:  Epilepsia       Date:  2011-11-16       Impact factor: 5.864

Review 4.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 5.  Bodyweight gain and anticonvulsants: a comparative review.

Authors:  P Jallon; F Picard
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  The impact of the use of antiepileptic drugs on the growth of children.

Authors:  Herng-Sheng Lee; Shih-Yu Wang; Donald M Salter; Chih-Chien Wang; Shyi-Jou Chen; Hueng-Chuen Fan
Journal:  BMC Pediatr       Date:  2013-12-19       Impact factor: 2.125

Review 7.  Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development.

Authors:  Abdul Wahab
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

8.  Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.

Authors:  Tingting Fu; Qingxia Kong; Huaqiang Sheng; Lingyun Gao
Journal:  Neural Plast       Date:  2016-01-27       Impact factor: 3.599

9.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

10.  Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis.

Authors:  Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.